| Product Code: ETC8952956 | Publication Date: Sep 2024 | Updated Date: Oct 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Republic of Moldova Lumasiran Market Overview |
3.1 Republic of Moldova Country Macro Economic Indicators |
3.2 Republic of Moldova Lumasiran Market Revenues & Volume, 2021 & 2031F |
3.3 Republic of Moldova Lumasiran Market - Industry Life Cycle |
3.4 Republic of Moldova Lumasiran Market - Porter's Five Forces |
3.5 Republic of Moldova Lumasiran Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.6 Republic of Moldova Lumasiran Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Republic of Moldova Lumasiran Market Revenues & Volume Share, By Dosage form, 2021 & 2031F |
3.8 Republic of Moldova Lumasiran Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.9 Republic of Moldova Lumasiran Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 Republic of Moldova Lumasiran Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Republic of Moldova Lumasiran Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare genetic diseases in Moldova |
4.2.2 Growing awareness and adoption of advanced therapies in the healthcare sector |
4.2.3 Supportive government policies and regulations for orphan drug development in the country |
4.3 Market Restraints |
4.3.1 Limited healthcare infrastructure and access to specialized treatments in certain regions of Moldova |
4.3.2 High costs associated with orphan drugs like lumasiran, impacting affordability for patients |
5 Republic of Moldova Lumasiran Market Trends |
6 Republic of Moldova Lumasiran Market, By Types |
6.1 Republic of Moldova Lumasiran Market, By Drug Class |
6.1.1 Overview and Analysis |
6.1.2 Republic of Moldova Lumasiran Market Revenues & Volume, By Drug Class, 2021- 2031F |
6.1.3 Republic of Moldova Lumasiran Market Revenues & Volume, By Miscellaneous Metabolic Agents, 2021- 2031F |
6.1.4 Republic of Moldova Lumasiran Market Revenues & Volume, By others, 2021- 2031F |
6.2 Republic of Moldova Lumasiran Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Republic of Moldova Lumasiran Market Revenues & Volume, By Primary Hyperoxaluria, 2021- 2031F |
6.2.3 Republic of Moldova Lumasiran Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Republic of Moldova Lumasiran Market, By Dosage form |
6.3.1 Overview and Analysis |
6.3.2 Republic of Moldova Lumasiran Market Revenues & Volume, By Injection, 2021- 2031F |
6.3.3 Republic of Moldova Lumasiran Market Revenues & Volume, By Solution, 2021- 2031F |
6.4 Republic of Moldova Lumasiran Market, By Route of Administration |
6.4.1 Overview and Analysis |
6.4.2 Republic of Moldova Lumasiran Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.4.3 Republic of Moldova Lumasiran Market Revenues & Volume, By Demographic, 2021- 2031F |
6.4.4 Republic of Moldova Lumasiran Market Revenues & Volume, By Adult, 2021- 2031F |
6.4.5 Republic of Moldova Lumasiran Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.5 Republic of Moldova Lumasiran Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 Republic of Moldova Lumasiran Market Revenues & Volume, By Clinics, 2021- 2031F |
6.5.3 Republic of Moldova Lumasiran Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.5.4 Republic of Moldova Lumasiran Market Revenues & Volume, By Diagnostic center, 2021- 2031F |
6.6 Republic of Moldova Lumasiran Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 Republic of Moldova Lumasiran Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 Republic of Moldova Lumasiran Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 Republic of Moldova Lumasiran Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Republic of Moldova Lumasiran Market Import-Export Trade Statistics |
7.1 Republic of Moldova Lumasiran Market Export to Major Countries |
7.2 Republic of Moldova Lumasiran Market Imports from Major Countries |
8 Republic of Moldova Lumasiran Market Key Performance Indicators |
8.1 Number of patients diagnosed with rare genetic diseases receiving lumasiran treatment |
8.2 Rate of adoption of lumasiran therapy in Moldovan healthcare facilities |
8.3 Investment in research and development of orphan drugs in the country |
9 Republic of Moldova Lumasiran Market - Opportunity Assessment |
9.1 Republic of Moldova Lumasiran Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.2 Republic of Moldova Lumasiran Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Republic of Moldova Lumasiran Market Opportunity Assessment, By Dosage form, 2021 & 2031F |
9.4 Republic of Moldova Lumasiran Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.5 Republic of Moldova Lumasiran Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 Republic of Moldova Lumasiran Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Republic of Moldova Lumasiran Market - Competitive Landscape |
10.1 Republic of Moldova Lumasiran Market Revenue Share, By Companies, 2024 |
10.2 Republic of Moldova Lumasiran Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here